Skip to Content
Skip to Content

Substance evaluation - CoRAP

Substance evaluation - CoRAP

If a substance is on this list, it means that a Member State has evaluated or will evaluate it over the coming years. The list is called the Community rolling action plan (CoRAP).

For each substance, the table shows the evaluating Member State, the (planned) year of evaluation and a short description of the concern which led to it being placed on the list.

Documents to do with substance evaluation are also available here. They include: documents justifying selection of the substances, decisions to request more information.  Member States' conclusions and Member States' final evaluation reports are included for substances for which evaluation has been finalised.

 

Notes to the Substance Evaluation table
  • Where two Members States are indicated, this is a joint evaluation. The first Member State mentioned leads the Evaluation and is the responsible competent authority in the meaning of Article 45(2) of REACH.
  • The substance public name is used. In most of the cases it is the name as disseminated on the ECHA website.
  • When the EC Number is not available, the number assigned to substance by ECHA after the inquiry process is used.
  • When the substances are included in the CoRAP, they have not yet been evaluated and thus the concern is indicative and not exhaustive or conclusive.
  • Contact details of the evaluating Member States are provided for all the substance included.
  • Please note that the justification document explains the grounds of the initial concerns that triggered the inclusion of the substance in the CoRAP for further clarification under substance evaluation. The justification document is based on a preliminary screening of the substance and is without prejudice to the outcome of the substance evaluation.

Legend:

Suspected PBT/vPvB: Potentially Persistent, Bioaccumulative and Toxic/very Persistent and very Bioaccumulative.
CMR: generic term for known carcinogenic and/or mutagenic and/or reprotoxic properties (according to CLP harmonised or registrant self-classification or CLP Inventory). The concern can refer to C, M, R or a combination of those.
Suspected CMR: generic term for suspected carcinogenic and/or mutagenic and/or reprotoxic properties (not classified according to CLP harmonised or registrant self-classification). The concern can refer to (suspected) C, M, R or a combination of those.
Sensitiser: generic term for known sensitising properties (according to CLP harmonised or registrant self-classification or CLP Inventory).
Suspected sensitiser: generic term for suspected sensitising properties (not classified according to CLP harmonised or registrant self-classification).
RCR: Risk Characterisation Ratio 

Last updated 20 October 2020. Database contains 382 unique substances/entries.
Filter the list
Initial grounds for concern:

 
202-112-7
91-97-4
2013
France
Suspected CMR
Suspected PBT/vPvB
Sensitiser
Consumer use
Concluded
Details
-
37486-69-4
2017
Germany
Suspected PBT/vPvB
Exposure of environment
Conclusion under preparation
Details
200-889-7
75-65-0
2013
United Kingdom
Suspected CMR
Consumer use
High (aggregated) tonnage
High RCR
Wide dispersive use
Concluded
Details
212-782-2
868-77-9
2014
France
Suspected CMR
Sensitiser
Consumer use
High (aggregated) tonnage
High RCR
Wide dispersive use
Conclusion under preparation
Details
202-627-7
98-01-1
2022
Denmark
Suspected Carcinogenic
Suspected Mutagenic
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Not started
Details
629-661-9
83834-59-7
2016
Germany
Potential endocrine disruptor
Suspected PBT/vPvB
Consumer use
Exposure of environment
High (aggregated) tonnage
Other exposure/risk based concern
Wide dispersive use
Information requested
Details
204-263-4
118-60-5
2022
Germany
Potential endocrine disruptor
Not started
Details
203-079-1
103-09-3
2015
Belgium
Suspected CMR
Consumer use
Wide dispersive use
Concluded
Details
260-828-5
57583-34-3
2015
Netherlands
CMR
High (aggregated) tonnage
Suspended
Details
248-227-6
27107-89-7
2022
Netherlands
Potential endocrine disruptor
Not started
Details
205-743-6
149-57-5
2012
Spain
CMR
Consumer use
High (aggregated) tonnage
High RCR
Wide dispersive use
Concluded
Details
203-234-3
104-76-7
2014
Poland
Suspected CMR
Consumer use
High (aggregated) tonnage
High RCR
Wide dispersive use
Concluded
Details
239-701-3
15625-89-5
2014
France
Sensitiser
Exposure of workers
High RCR
Wide dispersive use
Concluded
Details
484-410-9
-
2019
Spain
Suspected PBT/vPvB
Ongoing
Details
627-872-0
1514-82-5
2019
Spain
Suspected Reprotoxic
Potential endocrine disruptor
Concluded
Details
205-483-3
141-43-5
2014
United Kingdom
Suspected Sensitiser
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
266-733-5
67584-55-8
2018
Germany
Suspected PBT/vPvB
Other hazard based concern
Exposure of environment
Wide dispersive use
Concluded
Details
1 - 4.5 moles ethoxylated
500-082-2
32492-61-8
2022
France
Suspected Mutagenic
Potential endocrine disruptor
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Not started
Details
229-419-9
6528-34-3
2019
Italy
Suspected PBT/vPvB
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Ongoing
Details
229-355-1
6486-23-3
2019
Italy
Suspected PBT/vPvB
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Suspended
Details
228-768-4
6358-31-2
2019
Italy
Suspected PBT/vPvB
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Suspended
Details
405-490-3
613-62-7
2012
Czech Republic
Other hazard based concern
High (aggregated) tonnage
Concluded
Details
201-289-8
80-54-6
2012
Sweden
CMR
Consumer use
Wide dispersive use
Ongoing
Details
219-470-5
2440-22-4
2016
Czech Republic
Sensitiser
Consumer use
Exposure of workers
High RCR
Wide dispersive use
Concluded
Details
200-076-7
51-03-6
Sweden
Potential endocrine disruptor
Suspected PBT/vPvB
Consumer use
Wide dispersive use
Withdrawn
Details
226-866-1
5521-31-3
2022
Belgium
Suspected PBT/vPvB
Not started
Details
204-881-4
128-37-0
2016
France
Potential endocrine disruptor
Exposure of sensitive populations
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Ongoing
Details
622-542-2
3891-98-3
2021
Austria
Suspected Mutagenic
Suspected PBT/vPvB
Suspected Sensitiser
Consumer use
Exposure of environment
Exposure of workers
Not started
Details
201-222-2
79-74-3
2014
Italy
Suspected PBT/vPvB
High RCR
Follow-up
Details
249-820-2
29736-75-2
2018
Germany
Suspected Carcinogenic
Suspected Reprotoxic
Other hazard based concern
Exposure of workers
Information requested
Details
202-532-0
96-76-4
2017
Belgium
Suspected CMR
Potential endocrine disruptor
Consumer use
Wide dispersive use
Information requested
Details
203-614-9
108-77-0
2017
Poland
Suspected Reprotoxic
Suspected PBT/vPvB
Exposure of environment
High (aggregated) tonnage
Concluded
Details
204-278-6
118-79-6
2012
Norway
CMR
Suspected PBT/vPvB
High (aggregated) tonnage
High RCR
Wide dispersive use
Concluded
Details
211-989-5
732-26-3
2017
Belgium
Suspected PBT/vPvB
Exposure of environment
Concluded
Details
218-645-3
2210-79-9
2016
Denmark
Mutagenic
Information requested
Details
247-979-2
26761-45-5
2015
Denmark
Suspected CMR
Suspected Sensitiser
Consumer use
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Follow-up
Details
204-279-1
118-82-1
2014
Austria
Suspected CMR
Potential endocrine disruptor
Suspected PBT/vPvB
Suspected Sensitiser
Consumer use
Exposure of environment
Exposure of workers
Wide dispersive use
Information requested
Details
253-057-0
36483-57-5
2022
Denmark
Suspected Carcinogenic
Suspected Mutagenic
Not started
Details
201-236-9
79-94-7
2015
Denmark
Suspected Reprotoxic
Potential endocrine disruptor
Suspected PBT/vPvB
Consumer use
Exposure of environment
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Information requested
Details
203-872-2
111-46-6
2015
Hungary
Suspected CMR
Other hazard based concern
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
203-312-7
105-59-9
2013
United Kingdom
Suspected CMR
High (aggregated) tonnage
High RCR
Wide dispersive use
Concluded
Details
203-868-0
111-42-2
2012
Germany
Suspected CMR
High (aggregated) tonnage
Wide dispersive use
Information requested
Details
229-962-1
6864-37-5
2015
Germany
Potential endocrine disruptor
Ongoing
Details
216-823-5
1675-54-3
2015
Denmark
Suspected CMR
Potential endocrine disruptor
Consumer use
High (aggregated) tonnage
Wide dispersive use
Follow-up
Details
926-564-6
-
2016
Germany
Potential endocrine disruptor
Suspected PBT/vPvB
Exposure of environment
Information requested
Details
203-049-8
102-71-6
2014
United Kingdom
Suspected CMR
Suspected Sensitiser
Other hazard based concern
Consumer use
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
700-604-0
947701-81-7
Finland
Suspected PBT/vPvB
Consumer use
Withdrawn
Details
202-707-1
98-85-1
2019
Italy
Suspected Carcinogenic
Suspected Mutagenic
Consumer use
Exposure of workers
Wide dispersive use
Ongoing
Details
701-029-8
-
Estonia
CMR
Sensitiser
Consumer use
Wide dispersive use
Withdrawn
Details
216-475-4
1594-08-7
2019
Belgium
Suspected PBT/vPvB
Ongoing
Details

Export search results to:

Categories Display

Tagged as:

(click the tag to search for relevant content)


Route: .live2